AZ Hematology Hub

Featured Moments highlights of international experts' sessions captured in short videos.

 

 

EHA & ASCO updates in B-Cell malignancies

Acalabrutinib and Other Novel Therapies in Mantle Cell Lymphoma

Dr. Michael Wang, United States

Continues Therapy Versus Time Limited Therapy in High-Risk CLL Patients

Dr. Wojciech Jurczak, Poland

Optimizing the Usage of BTK Inhibitors in CLL

Dr. Cyrus Khan, US

Precision approach for CLL treatment

Critical Evaluation of BTKis in CLL

Dr. George Follows, UK

Latest Updates in Management of CLL

Dr. Davide Rossi, Switzerland

How to Choose BTK Inhibitors for CLL Patients?

Dr. Krish Patel, US

CLL Management 2023 - Year in Review

Review on Time to Progression Regimen in CLL Management

Dr. George Follows, UK